Brief: Mithra Pharmaceuticals Says PeriNesta Project Is No Longer Its Priority

Mithra Pharmaceuticals SA

21/09/2021 16:55

Sept 21 (Reuters) - Mithra Pharmaceuticals SA  MITRA.BR :
    * ANNOUNCES AN UPDATE ON PERINESTA
    * THE BOARD DECIDED THAT THE INITIAL PERINESTA® DEVELOPMENT PROJECT WAS NO
LONGER
TIMELY NOR A PRIORITY FOR THE COMPANY
    * ALTERNATIVE SCENARIOS BASED ON ESTELLE® AND DONESTA® COULD POTENTIALLY
TARGET
THIS PERIMENOPAUSAL MARKET WITHOUT INCURRING SUBSTANTIAL DEVELOPMENT COSTS
    * THE TARGETED MARKET AUTHORIZATION INITIALLY PLANNED FOR 2023 IS NO LONGER
ACHIEVABLE IN THIS OPPORTUNISTIC DEVELOPMENT PROJECT


Further company coverage:  MITRA.BR 

 (Gdansk Newsroom)
 ((Gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))